Stay updated on Melanoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Melanoma Immunotherapy Clinical Trial page.

Latest updates to the Melanoma Immunotherapy Clinical Trial page
- Check6 days agoChange DetectedThe change is a minor update to the site's revision/version label, from Revision: v3.3.3 to Revision: v3.3.4, and does not modify the study details, eligibility criteria, results, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded the NEJM 2015 paper citation for Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma (including the Erratum) and removed the earlier version of the citation.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA consolidated 'Locations' section lists trial sites across multiple regions, replacing the previous scattered location headings. This affects how users identify and access eligible sites.SummaryDifference2%

- Check56 days agoChange DetectedThe Publications section now states that PubMed publications are automatically filled for the study, and the page revision number was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check63 days agoChange DetectedThe government funding and operating status notice was removed from the page; this does not affect the study data or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check77 days agoChange DetectedThe two screenshots show the same Study Details page for NCT01844505 with no meaningful changes to core content. Any visible differences are minor UI/formatting adjustments that do not modify the information presented.SummaryDifference0.2%

Stay in the know with updates to Melanoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Melanoma Immunotherapy Clinical Trial page.